Picture of ReproCELL Incorporated logo

4978 — ReproCELL Incorporated News Story

0.000.00%
jp flag iconLast trade - 00:00
HealthcareHighly SpeculativeSmall CapSucker Stock

Table: Reprocell -Q1 group results

    Aug 13 (Reuters)- 
             Reprocell Incorporated 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 3 months ended      3 months ended       Year to  
                Jun 30, 2026        Jun 30, 2025      Mar 31, 2027 
                   LATEST             YEAR-AGO           LATEST    
                   RESULTS             RESULTS          FORECAST   
  Sales            546 mln             475 mln            2.63     
                 (+14.9 pct)         (-23.2 pct)      (+17.7 pct)  
  Operating     loss 310 mln        loss 291 mln      loss 630 mln 
  Recurring     loss 149 mln        loss 301 mln      loss 458 mln 
  Net           loss 149 mln        loss 304 mln      loss 458 mln 
  EPS           loss 1.56 yen       loss 3.21 yen    loss 4.68 yen 
  Ann Div                                NIL              NIL      
  -Q2 div                                NIL              NIL      
  -Q4 div                                NIL              NIL      
  
  NOTE - Reprocell Incorporated. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4978.T 
    
 
 

Recent news on ReproCELL Incorporated

See all news